USPTO serial 77950302
CCH
Reviewed by CopyMark Law Group
Reg. 3922019Status 710
- Filing date
- Status date
- Registration date
- Feb 22, 2011
- Examiner
- KHAN, ASMAT A
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly Gambrel
KIMBERLY GAMBREL DINSMORE & SHOHL LLPOne South Main Street, Suite 1200Fifth Third CenterDAYTON, OH 45402-2024Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ pharmaceutical, veterinary or medicinal preparations for quality control of human cartilage cells in vivo; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in monitoring the expansion and implanting of human cartilage cells in vivo for scientific purposes ] | SECTION 8 - CANCELLED | — |
| 005 | [ pharmaceutical, veterinary or medicinal preparations for the expansion and implanting of human cartilage cells in vivo; cultures and nutritional substrates for the expansion and implanting of human cartilage cells in vivo; medical in vitro diagnostic tests, namely, test strips, immunological assays and immunological products, namely, enzyme based assay systems for detection of markers of disease, for use in monitoring the expansion and implanting of human cartilage cells in vivo; hormones and substances designed for stimulating cell growth, namely, cell growth media for growing cells for medical or clinical purposes; enzymes for medical purposes; antibodies for medical purposes for the expansion of human cartilage cells in vivo ] | SECTION 8 - CANCELLED | — |
| 010 | surgical apparatus and instruments for medical or veterinary use, also in the form of kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo; biopsy kits comprising medical needles and medical syringes for harvesting, expansion and implanting of human cartilage cells in vivo, and containers for use as receptacles for harvested human cartilage cells; kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo | SECTION 8 - CANCELLED | — |
| 042 | [ pharmaceutical research services for the expansion and implanting of human cartilage cells in vivo; pharmaceutical drug development services for the expansion and implanting of human cartilage cells in vivo; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and diagnostics for the expansion and implanting of human cartilage cells in vivo ] | SECTION 8 - CANCELLED | — |
| 044 | pharmaceutical advice; dispensing of pharmaceuticals; pharmaceutical consultation; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of expansion and implanting of human cartilage cells; veterinary and medical services; implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical follow-up services in the field of diagnostic testing, and monitoring and reporting the expansion and implanting of human cartilage cells in vivo; medical follow-up services; medical testing, namely, carrying out of testing of expanded or implanted human cartilage cells for medical purposes; medical diagnostic testing and monitoring of the expansion and implanting of human cartilage cells in vivo | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TiGenix NV
- Other trademarks owned by TiGenix NV
- Other trademarks owned by TiGenix NV
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CCH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2021 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Feb 22, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 27, 2017 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 27, 2017 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Mar 25, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 16, 2017 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 22, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 7, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 4, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 4, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 14, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 24, 2010 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 13, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 11, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2010 | ALIE | ASSIGNED TO LIE | — |
| Aug 23, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2010 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Mar 9, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 8, 2010 | NWAP | NEW APPLICATION ENTERED | — |